InvestorsHub Logo
Followers 63
Posts 7611
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Monday, 02/10/2020 10:07:19 AM

Monday, February 10, 2020 10:07:19 AM

Post# of 430239
The Lilly Alzheimers drug trial failed...."Investors may not have been particularly confident of the Lilly trial’s success, but a functional Alzheimer’s disease treatment would have been so huge that lots of people made bets on the company anyway, on the remote chance that the drug would work."

The Lilly, Roche and Biogen trials, costing multiple billions of dollars, have all failed.

They were all predicated in the theory that Amyloid causes Alzheimers....THIS THEORY IS WRONG...INFLAMMATION OF THE BRAIN CAUSES ALZHEIMERS AND VASCEPA HELPS!...The VA study being done at the University of Wisconsin are soon to be released and the results will demonstrate that.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News